Advancements in tissue engineering have taken aim at treating tissue types that have
difficulty healing naturally. In order to achieve improved healing conditions, the balance of …

In recent years, the amnion (AM) has emerged as a versatile tool for stimulating tissue
regeneration and has been of immense interest for clinical applications. AM is an abundant …

Objective: To compare the effectiveness of cellular tissue products (CTP) versus standard
care in US Medicare beneficiaries with diabetic lower extremity ulcers (DLEUs) or venous …

Amniotic membranes (AM) have anti-fibrotic activity. Exosomes (nano-sized vesicles)
function as conduits for intercellular transfer and contain all the necessary components to …

The aim of this study was to compare concentrations of endogenous N-acylethanolamine
(NAE) lipid mediators—palmitoylethanolamide (PEA), oleoylethanolamide (OEA), and …

Perinatal derivatives have been proposed as adjunct therapeutic strategies or innovative
treatments. Undoubtedly, perinatal derivatives can offer the opportunity and source material …

Objective: To evaluate the clinical outcomes of lyopreserved placental membrane containing
viable cells (vLPM) in the treatment of nonhealing wounds of various etiologies, and to …

Mesenchymal stromal cells derived from the fetal placenta, composed of an amnion
membrane, chorion membrane, and umbilical cord, have emerged as promising sources for …

Amniotic membrane (AM) has been widely used as a biological dressing for many
pathologies and illnesses worldwide, and products derived from this tissue have been …

Fibrosis, the thickening and scarring of injured connective tissue, leads to a loss of organ
function. Multiple cell types, including T-cells, macrophages, fibrocytes, and fibroblasts …